کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
6158262 1598318 2010 12 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
An Economic Evaluation of Erythropoiesis-Stimulating Agents in CKD
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی بیماری‌های کلیوی
پیش نمایش صفحه اول مقاله
An Economic Evaluation of Erythropoiesis-Stimulating Agents in CKD
چکیده انگلیسی
Using ESAs to target a hemoglobin level >12 g/dL is associated with worse clinical outcomes and significant additional cost compared with using ESAs to target lower hemoglobin levels (9-12 g/dL). Given a lack of studies comparing low (9-10.9 g/dL) and intermediate (11-12 g/dL) hemoglobin targets for clinical outcomes, including quality of life, the most cost-effective hemoglobin level target within the range of 9-12 g/dL is uncertain, although aiming for higher targets within this range will lead to higher costs.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: American Journal of Kidney Diseases - Volume 56, Issue 6, December 2010, Pages 1050-1061
نویسندگان
, , , , , , , , , , ,